Masato Murakami
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis.
Journal: PloS one
Published: March 31, 2022
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells.
Journal: Molecular cancer therapeutics
Published: March 06, 2021
A Novel HER3-Targeting Antibody-Drug Conjugate, U3-1402, Exhibits Potent Therapeutic Efficacy through the Delivery of Cytotoxic Payload by Efficient Internalization.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 28, 2019
A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression.
Journal: PloS one
Published: April 10, 2019
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study.
Journal: International journal of hematology
Published: March 29, 2019
FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer.
Journal: Molecular cancer therapeutics
Published: December 16, 2018
Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf-/- mouse model.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 08, 2017
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
Journal: Cancer cell
Published: August 02, 2016
Last Updated: 09/26/2026